Spring Bank Pharmaceuticals Inc.

(SBPH) Trade

By |

Profile

Spring Bank Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of therapeutics using proprietary small molecule nucleic acid hybrid or SMNH, chemistry platform. These SMNH products can be used for the treatment of viral disease including hepatitis B virus.

Contact Information

Website: www.springbankpharm.com
Email: jfreve@springbankpharm.com
Main Phone: +1 508 473-5993
Address: 86 South Street
Address 2: Suite S-7
State: MA
City / Town: Hopkinton
Country: USA
Postal Code: 01748

Issuer Information

Exchange: NSC
CEO: Martin J. Driscoll
Employees: 21
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 10.02 $ -0.18 (-1.76%)
Last Price 10.02 Change $ -0.18 Change % -1.76 Tick N/A
Bid N/A Bid Size 0.00 Ask 15.54 Ask Size 1,000.00
Open 10.38 High 10.38 Low 10.00 Prev Close 10.20
Last Trade Volume 15,530 52 Wk Hi 15.95 52 Wk Low 8.88
Market Cap 132.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 13,185,092.00 EPS (TTM) -1.51 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 2 15
Number of Buys 2 15
Number of Sells 0 0
Net Activity 1414 89801
Last 10 Buys Shares
Martin J. Driscoll 1,000
Martin J. Driscoll 1,000
David A. Arkowitz 1,000
David A. Arkowitz 1,000
Martin J. Driscoll 1,000
Martin J. Driscoll 1,000
Kurt M. Eichler 1,000
Martin J. Driscoll 1,000
Kurt M. Eichler 1,000
Martin J. Driscoll 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 45 45 45 45
Low Target Price Estimate 20 20 20 20
Mean Target Price Estimate 31.25 31.25 31.25 31.25
Standard Deviation 8.18 8.18 8.18 8.18
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1